Good question.The CLBP and gvhd trial product ( the cells ) are...

Good question.

The CLBP and gvhd trial product ( the cells ) are allready paid for, and costs are split with investigators.

In my opinion.

Attempt BLA for Pediatric GvHD will submit and recieve a response prior to any CR needed. ( Approval decision this year, June to Dec sometime )

That is the biggest spanner. If pediatric gvhd is approved, company is selling product immediately as there are no alternative treatments. Ie , it will either partially or fully fund with paediatric plus off label use.

if pediatric gvhd flops, then cash will run out around June ish 2025
.. that is a rough estimate

CLBP won't finish until later.

Adult GvHD will finish before CLBP, but not before the end of 2025 IMO

Then the company has also a potential 100 million dollar valued review voucher . So on approval, another free 100million of funds available.

Then they also potentially have accelerated approval withCHF LVAD whoch could occur in 2024, but I think if it happens, is more likely to occur by mud 2025 - and there will likely be a huge partnership announcement when ir before this happens.

Bottom line..... funding from So many sources has never appeared so good as it does this year ( this year is full paid for based on a 15 mill quarter cash burn. ) with 10 mill extra left over in Dec